Articles tagged "Liver transplantation"

2020 American Transplant Congress
Combined Heart-Liver Transplantation Has Excellent Long-Term Outcomes
J. A. Steadman¹, J. M. Stulak¹, A. L. Clavell², S. S. Kushwaha², B. S. Edwards², N. L. Pereira², B. A. Boilson², A. Behfar², R. J. Rodeheffer², J. A. Dearani¹, T. Taner³, R. C. Daly¹
¹Division of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, ²Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN, ³Division of Transplantation Surgery, Mayo Clinic, Rochester, MN
*Purpose: Combined heart-liver transplants (CHLTx) have been shown to have good short-term outcomes in those with end-stage heart and liver disease: we conducted a comprehensive…
2020 American Transplant Congress
Post-Transplant Renal Function in ACLF Patients Based on Pre-Transplant Severity of Renal Dysfunction without Kidney Transplant
M. Yazawa¹, B. Maliakkal¹, S. Nair¹, Y. Jiang², P. S. Podila³, U. A. Agbim¹, S. Karri⁴, S. D. Khan⁵, D. Maluf¹, J. D. Eason¹, M. Z. Molnar¹, S. K. Satapathy⁶
¹James D. Eason Transplant Institute, Methodist University Hospital, Memphis, TN, ²Division of Epidemiology, Biostatistics, and Environmental Health, The University of Memphis, Memphis, TN, ³Faith & Health Division, Methodist Le Bonheur Healthcare, Memphis, TN, ⁴Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, ⁵Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, ⁶Sandra Atlas Bass Center for Liver Diseases & Transplantation, Department of Medicine, Northshore University Hospital/Northwell Health, Manhasset, NY
*Purpose: It is unknown whether severity of renal dysfunction in ACLF patients impacts outcome of ACLF patients compared to those without ACLF.*Methods: In a single…
2020 American Transplant Congress
Liver Transplantation in Obese Recipients: Post-Transplant Weight Gain and Outcomes
D. Soma¹, Y. Park¹, P. Mihaylov¹, B. Ekser¹, M. S. Ghabril², M. A. Lacerda², N. Chalasani², R. S. Mangus¹, C. A. Kubal¹
¹Transplant Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, ²Transplant Hepatology, Division of Gastroenterology, Indiana University School of Medicine, Indianapolis, IN
*Purpose: Non-alcoholic fatty liver disease is now the most common cause of end-stage liver disease necessitating orthotopic liver transplantation (OLT) in the United States. Several…
2020 American Transplant Congress
Outcome of Hepatitis B Virus DNA-Positive Liver Transplantation in Hepatitis B Virus/Hepatitis D Virus Co-Infected Recipient Treated with High Dose Hepatitis B Immune Globulin: A Case Report
M. B. Hammami¹, M. Haris¹, L. Toman¹, N. Danis¹, B. Saberi², E. King³, J. Garonzik-Wang³, B. Philosophe³, A. M. Cameron³, A. Gurakar¹
¹Gastroenterology and Hepatology, Johns Hopkins, Baltimore, MD, ²Gastroenterology and Hepatology, Icahn School of Medicine at Mount Sinai, New York, NY, ³Transplant Surgery, Johns Hopkins, Baltimore, MD
*Purpose: Introduction: While common in Asian countries, liver transplantation (LT) for patients with hepatitis B virus (HBV)/hepatitis D virus (HDV) co-infection is rare in the…
2020 American Transplant Congress
DCD vs DBD Liver Transplantation: Equivalent Charges and Similar Survival- An Effective Expansion of the Donor Pool
N. Singh, K. Helfrich, M. Alebrahim, C. Akateh, K. Mumtaz, A. Logan, A. Schenk, S. Black, E. Elkhammas, K. Washburn, A. El-Hinnawi
Ohio State University, Columbus, OH
*Purpose: The shortage of allografts available for liver transplantation (LT) has prompted the need for expansion of donor pool to include donation after circulatory death…
2020 American Transplant Congress
Liver Transplant Recipients with BMI 40 to <50 kg/m² Have Excellent Patient and Graft Survival
K. Daniel, J. Hause, F. Osman, J. Mezrich, E. Spengler
University of Wisconsin School of Medicine and Public Health, Madison, WI
*Purpose: Obesity rates in the United States (US) have reached nearly 40%, which has led to an increasing proportion of liver transplant (LT) candidates with…
2020 American Transplant Congress
Public Health Insurance is Associated with Reduced Access to Living Donor Liver Transplantation and Increased Liver Transplant Waiting List Mortality: An Analysis of the SRTR
R. Hogen¹, M. Aljehani², J. Lee³, L. Sher¹, Y. Genyk¹, J. Emamaullee¹
¹Surgery, Division of Hepatobiliary and Abdominal Organ Transplant Surgery, University of Southern California, Los Angeles, CA, ²Surgery, University of Southern California, Los Angeles, CA, ³Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California, Los Angeles, CA
*Purpose: Living donor liver transplantation (LDLT) is associated with improved survival and lower hospital costs, but it continues to makes up less than 5% of…
2020 American Transplant Congress
Effects of Mandatory 6-Month Waiting Time Policy on Post-Transplant Outcomes and Explant Pathology in Liver Transplant Patients with Hepatocellular Carcinoma
S. Nagai, T. Kitajima, S. Yeddula, R. Salgia, M. Abouljoud, D. Moonka
Henry Ford Hospital, Detroit, MI
*Purpose: In the United States, current allocation policy mandates a 6-month waiting period before exception scores are granted to liver transplant (LT) candidates with hepatocellular…
2020 American Transplant Congress
Delayed Kidney Transplant (KT) up to 2 Days in Combined Liver-Kidney Transplantation (CLKT) Offers Similar Renal Function as KT Alone: Comparison Analysis with Mate Kidneys
B. Ekser¹, E. Taber-Hight², P. Mihaylov¹, C. A. Kubal¹, R. S. Mangus¹, J. A. Fridell¹, A. J. Lutz¹, O. Adebiyi³, T. E. Taber³, A. Sharfuddin³, M. S. Yaqub³, D. P. Mishler³, M. D. Anderson³, J. A. Powelson¹, W. C. Goggins¹
¹Division of Transplant Surgery - Indiana University, Indianapolis, IN, ²Division of Nephrology, Indiana University, Indianapolis, IN, ³Division of Nephrology - Indiana University, Indianapolis, IN
*Purpose: Delayed KT in CLKT (Indiana Approach) offers a less hostile environment with hemodynamically more stable patient at the time of KT. Positive impact of…
2020 American Transplant Congress
Multiplexed Imaging Mass Cytometry Analysis Reveals a New Role for CD68+ Macrophages in Chronic Liver Transplant Rejection
J. Emamaullee, C. Man, J. Hoeflich, N. Ung, R. Sun, N. Matasci, J. Katz, J. Lee, S. Chopra, L. Sher, S. Asgharzadeh, O. Akbari, Y. Genyk
University of Southern California, Los Angeles, CA
*Purpose: Rejection continues to be an important cause of graft loss and failure post-liver transplant (LT). Recently, a novel high-resolution mass spectrometry-based technique has been…